Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Alan Kersey
AddedMar 31, 2024
UpdatedMay 31, 2026
Alan Kersey

Alan Kersey

Founder & CEO, CytoVeris

CrunchbaseLinkedIn

Alan Kersey's Career

CytoVeris
CytoVeris

Farmington, CT, US

Founder & CEO· C-Suite · Management
Cidra Corporate Services
Cidra Corporate Services

Wallingford, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Alan Kersey's Career

CytoVeris
CytoVeris
Series B$8M232018Farmington, CT, US
Founder & CEO· C-Suite · Management

Similar to CytoVeris

Vergent BioscienceVergent BioscienceMinneapolis, MN, USImaging Agentsest. 2016Vergent BioscienceMinneapolis, MN, US · est. 2016

Vergent Bioscience: Pioneering in tumor-targeted molecular imaging for cancer surgery.

Series B · $34.4M13
Cision VisionCision VisionMountain View, CA, USBiotechnology Productsest. 2021Cision VisionMountain View, CA, US · est. 2021

Cision Vision: Innovating pathology with advanced biotech imaging products, sans injections.

Angel · $256k30
Sanus SolutionsSanus SolutionsAtlanta, GA, USMedical Softwareest. 2017Sanus SolutionsAtlanta, GA, US · est. 2017

Sanus Solutions: AI-powered medical software for real-time monitoring and prevention of surgical infections.

Seed · $20k2
surgical.aisurgical.aiBoston, MA, USSurgical Solutionsest. 2011surgical.aiBoston, MA, US · est. 2011

Surgical.ai: Building innovative healthcare tech solutions.

7
Cidra Corporate Services
Cidra Corporate Services
Series B$132.1M701996Wallingford, CT, US
Board Member· Board

Leadership at Cidra Corporate Services

David VogelDavid VogelBoard Member
F Kevin DiddenF Kevin DiddenFounder

Similar to Cidra Corporate Services

Via SeparationsVia SeparationsWatertown, MA, USIndustrial Solutionsest. 2016Via SeparationsWatertown, MA, US · est. 2016

Via Separations: Enhancing sustainability in industrial processes through resource-efficient solutions.

Seed · $57.4M50
LixiviaLixiviaSanta Barbara, CA, USMineral Purificationest. 2012LixiviaSanta Barbara, CA, US · est. 2012

Lixivia: A venture-backed start-up offering cost-effective, scalable mineral purification solutions.

Seed · $650k6
DisaDisaCasper, WY, USMining, Technologyest. 2018DisaCasper, WY, US · est. 2018

Disa optimizes resource use with innovative liberation technology, enhancing mining practices and reducing environmental impact.

Series A · $15.7M30
DataCloudDataCloudSeattle, WA, USAnalytics, Softwareest. 2016DataCloudSeattle, WA, US · est. 2016

DataCloud: Real-time analytics provider, revolutionizing mining economics with breakthrough subsurface tech.

Public · $13M30

Alan Kersey's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to Alan Kersey

Jeremy AllaireJeremy AllaireBoard Member · Ping IdentityJeff PollockJeff PollockFounder · MB Growth PartnersKenneth KelleyKenneth KelleyBoard Member · SeromYx SystemsKeith E SchaeferKeith E SchaeferBoard Member · University of PittsburghAlex NociferaAlex NociferaCo-Founder & CEO · Field Day